Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Two researchers at the University of California, Davis, have been awarded a VinFuture Prize in recognition of their work ...
The genetically engineered food is also protein packed and sustainable, say scientists. Chinese researchers used gene-editing ...
Cambridge-based Fulcrum Therapeutics said it will aim to launch a large clinical trial in the second half of 2026 to prove ...
Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...
An interview with the devs of Super Animal Royale as Super Animal World, the new expansion, prepares for release.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback